retatrutide phase 2 results obesity nejm 2023 GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Weight Regain after Stopping Obesity

Some researchers report stability up to 6-8 weeks under strict sterile conditions, but the conservative recommendation is 4 weeks

Patients taking GLP-1 agonists most commonly complain of gastrointestinal effects, 2 such as unsettled stomach, upset GI tract, variable bowel movements or trouble with elimination, abdominal discomfort, and gastroesophageal discomfort

Inconsistent purity, lack of regulatory compliance, and opaque supply chains are persistent pain points that can derail research or product launches

This is a major step forward for patients with obstructive sleep apnea. OSA, a condition affecting as many as 30 million Americans, is characterized by breathing disruptions during sleep caused by blocked airflow

Blurry Vision: Fluctuating blood sugar levels (glucose levels) may cause changes in the lens of the eye, causing temporary blurry vision